Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics Article

Gil-Chinchilla, Jesus I, Bueno, Carlos, Martinez, Carlos M et al. (2024). Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics . FRONTIERS IN IMMUNOLOGY, 15 10.3389/fimmu.2024.1385691

Open Access International Collaboration

cited authors

  • Gil-Chinchilla, Jesus I; Bueno, Carlos; Martinez, Carlos M; Ferrandez-Murtula, Ana; Garcia-Hernandez, Ana M; Blanquer, Miguel; Molina-Molina, Mar; Zapata, Agustin G; Sackstein, Robert; Moraleda, Jose M; Garcia-Bernal, David

sustainable development goals

authors

publication date

  • March 28, 2024

published in

keywords

  • ADIPOSE-TISSUE
  • BONE-MARROW
  • CLINICAL-TRIAL
  • E-SELECTIN
  • E-selectin ligand
  • HCELL
  • HCELL EXPRESSION
  • IN-VIVO
  • INTRAVENOUS-INFUSION
  • Immunology
  • Life Sciences & Biomedicine
  • STEM-CELLS
  • STORAGE
  • Science & Technology
  • VERSUS-HOST-DISEASE
  • cell therapy
  • cryopreservation
  • exofucosylation
  • immunomodulation
  • mesenchymal stromal cells

Digital Object Identifier (DOI)

publisher

  • FRONTIERS MEDIA SA

volume

  • 15